Literature DB >> 1909735

Immunosuppression induced by attenuated Salmonella. Reversal by IL-4.

B K al-Ramadi1, Y W Chen, J J Meissler, T K Eisenstein.   

Abstract

We previously demonstrated that an aroA- strain of Salmonella typhimurium, which provides excellent protection against virulent Salmonella challenge, also rendered immunized mice unable to mount in vivo and in vitro antibody responses to heterologous Ag. Coculture studies using transwell plates indicated that suppression was mediated by soluble factors. The suppressive cells were identified as belonging to the monocytic linkage. Macrophage precursors as well as mature adherent macrophages mediated the observed suppression. In the present study, the mechanism of immunosuppression was investigated. Suppression was found to be genetically nonrestricted as spleen cells from immunized C3HeB/FeJ mice (H-2k) suppressed the anti-SRBC plaque-forming cell (PFC) responses of normal spleen cells from two MHC noncompatible mouse strains, BALB/c (H-2d) and C57BL/6 (H-2b). Time course experiments demonstrated that the addition of spleen cells from immunized mice to normal splenocytes as late as day 4 of a 5-day assay was still markedly suppressive. Furthermore, suppression of the PFC responses was accompanied by a profound inhibition of the capacity of immune splenocytes to produce IL-2 in response to in vitro stimulation by Con A. Coculture studies showed that immune spleen cells were able to suppress IL-2 production by normal splenocytes in a dose-dependent fashion. However, the suppressed PFC responses of immune spleen cells could not be reversed by the exogenous addition of up to 200 U/ml of IL-2, suggesting that immune splenocytes are also defective in their ability to respond to IL-2. In marked contrast, suppression of PFC responses was reduced by more than 50% by the addition of as little as 1 U/ml of IL-4 and was completely abrogated when 5 U/ml of IL-4 were added to in vitro cultures of spleen cells from immunized mice. The antisuppressive action of IL-4 appeared to be via its inhibitory effect on activated macrophages. The implications of the above findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909735

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Tracking the dynamics of T-cell activation in response to Salmonella infection.

Authors:  Rajesh Ravindran; Stephen J McSorley
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

2.  Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity.

Authors:  Douglas M Heithoff; Elena Y Enioutina; Diana Bareyan; Raymond A Daynes; Michael J Mahan
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

3.  Reversal of lipopolysaccharide-analog-induced antibody suppression by anti-transforming growth factor beta and indomethacin.

Authors:  M J Odean; A G Johnson; M Mohrman; A Hasegawa
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

4.  Attenuated Salmonella vaccine-induced suppression of murine spleen cell responses to mitogen is mediated by macrophage nitric oxide: quantitative aspects.

Authors:  D Huang; M G Schwacha; T K Eisenstein
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing.

Authors:  K Denich; P Börlin; P D O'Hanley; M Howard; A W Heath
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

6.  Specific and natural antibody production during Salmonella typhimurium infection in genetically susceptible and resistant mice.

Authors:  P Matsiota-Bernard; W Mahana; S Avrameas; C Nauciel
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

7.  Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection.

Authors:  Tanner M Johanns; James M Ertelt; Jared H Rowe; Sing Sing Way
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

8.  Virulent Salmonella typhimurium-induced lymphocyte depletion and immunosuppression in chickens.

Authors:  J O Hassan; R Curtiss
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis.

Authors:  M Dunne; B K al-Ramadi; S W Barthold; R A Flavell; E Fikrig
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Immunotherapy of a plasmacytoma with attenuated salmonella.

Authors:  T K Eisenstein; B Bushnell; J J Meissler; N Dalal; R Schafer; H F Havas
Journal:  Med Oncol       Date:  1995-06       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.